Margolis Scholars in Health Policy and Management

The Duke-Margolis Center for Health Policy and the Sanford School of Public Policy invite highly qualified Master of Public Policy applicants who have demonstrated strong interest in health policy or have experience in the health field to apply for the inaugural class of Margolis Scholars, entering the Master Public Policy (MPP) degree program at Sanford in Fall 2017. Margolis Scholars are linked with the world-class experts and leading-edge research of Duke-Margolis on the Duke University campus and in Washington, DC. Margolis Scholars will be considered for competitive scholarships, as well as paid summer internships that provide hands-on experience in health policy and management. The application deadline is January 5, 2017.

Watch the Video and Learn More

What the Election Means:  Health Care in NC

Don Taylor, PhD, provides analysis for North Carolina Health News and the Asheville Citizen-Times.

Copay Assistance for Expensive Drugs Raises Costs
As companies like Mylan, manufacturer of the Epipen, face outrage for prescription drug costs, manufacturers say they cushion the impact of high prices on patients by assisting with copays – but is this policy good for everyone? In an opinion piece published in the Annals of Internal Medicine, Peter Ubel, professor of business, medicine and public policy at Duke University and a member of Duke-Margolis, teamed up with Peter Bach of Memorial Sloan Kettering's Center for Health Policy and Outcomes to argue that copay assistance is not a solution, but in fact plays an integral role in prescription drug prices, which are one of the fastest growing components of healthcare costs. Read more.

Biological Variability to Drug Response:  Meeting Summary

Duke-Margolis released a summary of an expert workshop convened in May to examine regulatory and scientific issues relating to individual variation in responses to the same medication. Accurately predicting and addressing the effects of biologic variability during drug development is a source of growing concern for researchers, drug sponsors, and regulators. 

With NCI Funding, DCI, Vivor Partner on Mobile Financial Assistance Tool

Yusef Zafar, MD, MHS, a member of Duke-Margolis and Duke Cancer Institute, leads the work, which aims to reduce the financial toxicity of cancer care.  Read more.

Greg Daniel, MPH, PhD, RPh was an invited speaker on November 2 at the FDA:  Medical Device User Fee Amendments Public Meeting.  He also provided the keynote at the Transcatheter Cardiovascular Therapeutics Meeting in Washington on October 31st, "National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions”.

Biosimilar Event Covered by NPR
Duke-Margolis and Friends of Cancer Research's public event on the future of biosimilars in the United States was covered by NPR Health News. Read more.

Jennifer Potts (Innovations in Healthcare), Nick Pearson (Duke Global Health Institute) and  Zeena Johar (Duke Margolis Center for Health Policy) moderated a panel discussion on "Get Ready! Funding and social impact capital: healthcare innovator insights from East Africa, India and Latin America" at the Higher Education Solutions Network (HESN)’s Technical Convening (TechCon) 2016, co-hosted by MIT and USAID. 

Krishna Udayakumar, MD, presented at an event hosted at CSIS (Center for Strategic and International Studies) on  'Innovations in Healthcare' in Washington DC on November 9th, 2016. The panel discussion was chaired by Richard M. Rossow (Senior Fellow and Wadhwani Chair in U.S.-India Policy Studies), along with Sunil Wadhwani (Founder Donor, WISH Foundation), Catherine Robinson (Director, International Government Affairs, Pfizer) and Roslyn Docktor (Director, Health Policy Middle East and Africa). Learn more.